The 20 Best Hereditary Retinoblastoma Doctors Near Me in Ann Arbor, MI

Eric Liao is a Radiologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Liao is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Meningioma, Pediatric Low-Grade Glioma (pLGG), Arachnoid Cysts, and Neurofibromatosis Type 2 (NF2). Dr. Liao is board certified in Neuroradiology and Diagnostic Radiology.

Hakan Demirci is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Demirci is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Retinoblastoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.

Steven Archer is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Archer is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Strabismus, Esotropia, Brown Syndrome, and Amblyopia.

Victor Elner is a Pathologist and an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Elner is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Graves Disease, Melanoma of the Eye, Entropion, and Isolated Duane Retraction Syndrome.

Dr. Sedig was born and raised in Orlando, Florida. She completed her undergraduate degree in Medical Ethics at Davidson College before returning to Florida to attend the University of Florida College of Medicine. She then went to the University of Wisconsin-Madison for her residency in Pediatrics and then to the University of Michigan for her Pediatric Hematology/Oncology Fellowship. Dr. Sedig is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Hepatoblastoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration.

Rama Rao is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Rao is board certified in Pediatric Hematology-Oncology.

My past and ongoing research is focused on translational studies and clinical trials for children with brain and spinal cord tumors with a special emphasis on ependymoma and ATRT. Children with brain tumors continue to have poor outcomes compared to those with other cancers in this age group. I have analyzed the outcomes of treatment for ATRT and ependymoma in children, combining traditional modes of therapy, such as surgery, chemotherapy, and radiation therapy, with molecularly targeted therapy. In the process we have identified novel clinical and molecular risk factors associated with outcomes. By identifying clinical risk factors associated with poor outcomes in these children, we can tailor therapy to improve outcomes in those at highest risk of treatment failures. Dr. Upadhyaya is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Teratoma of the Mediastinum, Glioma, Medulloblastoma, and Bone Marrow Aspiration.

Emily B. Walling MD, MPHS is a Clinical Assistant Professor in the Division of Hematology/Oncology, Department of Pediatrics. Dr. Walling received her bachelor's degree from the University of Wisonsin-Madison and her medical degree from the University of Toledo. Following residency training in pediatrics at the Medical College of Wisconsin, Dr. Walling completed her fellowship training in pediatric hematology-oncology at Washington University where she earned her master's degree in population health sciences. Dr. Walling joined the faculty at Michigan in 2016. She founded and is the co-medical director of the Michigan Medicine Adolescent and Young Adult Oncology Program. Dr. Walling is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Hereditary Neuroblastoma, Neuroblastoma, Osteosarcoma, and Bone Marrow Aspiration. Dr. Walling is board certified in Pediatric Hematology-Oncology and Pediatrics.

Joshua Goldman is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Goldman is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Hereditary Neuroblastoma, Febrile Neutropenia, and Bone Marrow Aspiration. Dr. Goldman is board certified in Pediatrics and Pediatric Hematology-Oncology.

Dr. Chaudhary is a physician/surgeon scientist and a practicing Neurointerventionalist for the past 15 years. He is a neurovascular imaging expert as well. His training background is pretty diverse, with medical school in India, graduate and postgraduate training in general surgery and general radiology in United Kingdom followed by fellowships in Neurointerventional Radiology (NIR) and Neuro-Diagnostic Radiology (NDR) in adults and children in London, England, UK and at the University of Michigan in USA. He treats neurovascular and other diseases of the brain and spinal cord including its bony casing plus Head Neck Face and orbit vascular malformations in both adults and children. He has over 180 peer reviewed publications to his name and is a keen translational researcher of Hemorrhagic and Ischemic stroke. He extensively reviews manuscripts for several national and international journals of repute in the fields of Neurointervention and Neuroimaging. Apart from his primary appointment in the department of Radiology, he has dry appointments in the departments of Neurosurgery, Neurology and Otorhinolaryngology. In the spirit of collaborative care for patients, which is at the core of the mission of Michigan Medicine, his team are part of the comprehensive stroke center, spine oncology program and the retinoblastoma treatment program at our institution. Dr. Chaudhary is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Arteriovenous Malformation, Stroke, Brain Aneurysm, Thrombectomy, and Stent Placement.

Grace Wang is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Esotropia, Strabismus, Amblyopia, and Oculomotor Apraxia Cogan Type.

Marguerite Weinert is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Weinert is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Amblyopia, Strabismus, Esotropia, and Retinopathy of Prematurity. Dr. Weinert is board certified in Ophthalmology.

Dr. Jacobson completed residency in New York and a fellowship in pediatricophthalmology at the Kellogg Eye Center. His interests include medicaleducation and pediatric glaucoma. He is currently one of the associatemedical student clerkship directors and manages patients with pediatricglaucoma at the University of Michigan. Dr. Jacobson is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Stickler Syndrome, Axenfeld-Rieger Syndrome, Microphthalmia, Trabeculectomy, and Vitrectomy. Dr. Jacobson is board certified in Ophthalmology.

Christopher Gappy is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Gappy is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Strabismus, Esotropia, Oculomotor Apraxia Cogan Type, and Amblyopia.

Cagri Besirli is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Besirli is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Stickler Syndrome, Vitrectomy, and Trabeculectomy. Dr. Besirli is board certified in Ophthalmology.

Christopher Hood is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Hood is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Fuchs Dystrophy, Interstitial Keratitis, Cloudy Cornea, Corneal Transplant, and Vitrectomy.

Dr. Andrea (Flynn) Franson received her bachelor's degree from Rensselaer Polytechnic Institute in Troy, New York and her medical degree from the University of Michigan Medical School. She completed her residency in pediatrics and fellowship in pediatric hematology/oncology at the Children's Hospital of Philadelphia (CHOP). During fellowship, she earned a master's degree in Pharmacology from Thomas Jefferson University in Philadelphia. While at CHOP, she was an Alex's Lemonade Stand Foundation Center of Excellence Scholar, through which she had mentored training in clinical trial design and pharmacology. Dr. Franson has focused her research efforts in translational research science, working to transition the most promising compounds into the clinic for children with cancer. Dr. Franson is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Glioma, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, Neuroblastoma, and Bone Marrow Aspiration.

Dr. Koschmann is a Pediatric Neuro-Oncologist in the Department of Pediatrics and a Principal Investigator of an independent translational Pediatric Neuro-Oncology laboratory. His work in the clinic and lab complement and drive each other, resulting in a clear goal to improve therapies for children with brain tumors. He has engaged in research and the clinical care of pediatric brain tumor patients at both Seattle Children’s Hospital and the University of Michigan’s Mott Children’s Hospital. The Koschmann laboratory is exploring the molecular mechanisms by which recurrent mutations in pediatric high-grade glioma (HGG), including glioblastoma (GBM), anaplastic astrocytoma (AA) and diffuse intrinsic pontine glioma (DIPG) promotes tumor formation and affect treatment response.Dr. Koschmann has applied this precision medicine approach in translational and clinical work in Pediatric Neuro-Oncology. Along with researchers and colleagues from multiple clinical divisions at the University of Michigan and other institutions, he developed and co-facilitate the UM CNS Precision Medicine conference. In this multi-disciplinary and multi-institutional conference, molecular results are incorporated from pediatric brain tumor patients (paired tumor/germline sequencing results and pre-clinical cell culture treatment studies) into their treatment. Dr. Koschmann has established new algorithms and are in the process of developing multiple clinical trials incorporating the use of molecularly targeted therapy for pediatric patients with brain tumors. He will serve as PI for these trials and their biologic correlative research. Dr. Koschmann is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Brain Stem Cancer, and Embryonal Tumor with Multilayered Rosettes. Dr. Koschmann is board certified in Pediatric Hematology-Oncology and Pediatrics.

Jennifer Agrusa is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Agrusa is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Agrusa is board certified in Pediatric Hematology-Oncology and Pediatrics.

Jay Read is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Read is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Chediak-Higashi Syndrome, Neuroblastoma, Hereditary Neuroblastoma, and Aplastic Anemia. Dr. Read is board certified in Pediatric Hematology-Oncology and Pediatrics.